Skip to content
Toggle main navigation
Boost logo
Boost logo
  • Home
  • Welcome
    • Community Guidelines
    • Platform Features
  • My Boost Learning Journey
    • Climate Resilient Immunization
    • Storytelling for Change
    • Boosting Leadership to Activate Communities
    • Advanced Community Activation Training
    • COVID-19 Recovery for Routine Immunization Programs Fellowship
  • News & Resources
  • Bright Spots
    • Sparks
    Log in
    Request to join

    News & Resources

    Check out the latest news and resources below from the Boost Community and its global partners!

    Filter by category
    All
    Advocacy & Communications
    Boost Community News
    Brief
    Bright Spots
    Courses or Trainings
    Disease Surveillance, Investigation & Response
    Equity
    Featured Resource
    Global Updates
    Human Resources & Performance Management
    See all

    Highlighted News

    Results (108)

    UN Foundation: Aligning Global Health Reforms in 2026

    UN Foundation: Aligning Global Health Reforms in 2026

    🌍 Aligning Global Health Reforms for 2026The UN Foundation explores how a shifting global health landscape — from shrinking donor budgets and USAID restructuring to rising calls for national health sovereignty — is driving urgent reform discussions ahead of key governance moments in 2026. The article highlights opportunities for institutions like WHO, Gavi, and the Global Fund to shape a more coh
    January 12, 2026
    Think Global Health: Transforming the Global Health Ecosystem for a Healthier World in 2026

    Think Global Health: Transforming the Global Health Ecosystem for a Healthier World in 2026

    🌐 Rethinking Global Health for 2026 and BeyondLeading global health thinkers call for a transformative overhaul of the global health ecosystem — urging a shift toward country-driven priorities, greater efficiency and equity, and stronger global public goods like surveillance and innovation. With donor funding declining and systems fragmented, the piece lays out 10 strategic considerations to buil
    January 12, 2026
    Gavi: What are the biggest vaccine breakthroughs coming in 2026? We asked five experts

    Gavi: What are the biggest vaccine breakthroughs coming in 2026? We asked five experts

    🌍 What’s Next in Vaccines? Experts Share 2026’s Most Exciting BreakthroughsFrom cutting-edge mRNA advances and needle-free delivery to maternal RSV protection, enteric vaccines, and the latest in HIV vaccine research, top global health leaders outline the innovations set to shape vaccine science and equity in 2026. Get a glimpse of the future of immunization and what it could mean for global heal
    January 12, 2026
    📢 New WHO–UNICEF Report Alert!

    📢 New WHO–UNICEF Report Alert!

    📢 New WHO–UNICEF Report Alert!Global childhood vaccination coverage held steady in 2024—but 14.3 million infants still missed out on lifesaving vaccines. Boosters, this is a critical reminder of why our work matters. Let’s stay informed and committed to reaching every child.Read the Full Update!Access New Estimates!
    July 15, 2025
    Gavi and Asian Development Bank Sign New Partnership to Boost Health Financing for Immunisation

    Gavi and Asian Development Bank Sign New Partnership to Boost Health Financing for Immunisation

    Gavi and the Asian Development Bank have signed a new partnership to scale up sustainable health and immunization financing across 32 countries in the region. The agreement aims to support countries transitioning from Gavi aid to self-financed programs—strengthening systems through loans, grants, and technical support.Read More!
    June 12, 2025
    Pertussis in 2025: A Conversation with Prof. Gordon Dougan

    Pertussis in 2025: A Conversation with Prof. Gordon Dougan

    A recent Q&A with Prof. Gordon Dougan (Sabin Gold Medal recipient) spotlights a concerning global rise in pertussis cases—especially in the U.S., where 2024 reported six times more cases than 2023. He emphasizes the danger to infants: "persistent long‑whooping cough… gulping for air… for weeks," making clear why timely vaccination and improved diagnostics are essential. State-level data reflect th
    June 12, 2025
    Strategic Advisory Group of Experts on Immunization (SAGE) - March 2025

    Strategic Advisory Group of Experts on Immunization (SAGE) - March 2025

    The Strategic Advisory Group of Experts on Immunization (SAGE) convened from March 10–13, 2025, at WHO headquarters in Geneva. This meeting brought together global immunization experts to review and provide recommendations on vaccine policies and strategies. Key topics included updates on vaccine-preventable diseases, immunization coverage, and emerging vaccine technologies. Meeting materials such
    May 28, 2025
    Sabin Begins Marburg Vaccine Trial in U.S.

    Sabin Begins Marburg Vaccine Trial in U.S.

    Sabin has launched a Phase 2 Marburg virus vaccine trial in the U.S., building on studies in Kenya and Uganda. The trial will assess safety and immune response in 200 adults across four U.S. sites. Read more about this critical step toward protecting against future outbreaks.Access the Article!
    May 28, 2025
    Gavi: 9 million vaccine doses administered to children living in humanitarian settings in the Horn of Africa

    Gavi: 9 million vaccine doses administered to children living in humanitarian settings in the Horn of Africa

    Gavi administered 9 million vaccine doses to children in humanitarian settings across the Horn of Africa, helping to address health challenges exacerbated by conflict, displacement, and climate change. This initiative aims to reduce outbreaks and improve health equity for vulnerable populations. To learn more, click the link below!Access Now!
    February 25, 2025
    Watch Sabin's "Getting to Zero" Episode: Bringing Cervical Cancer Care to Local Settings - Dr. Zainab Bagudu

    Watch Sabin's "Getting to Zero" Episode: Bringing Cervical Cancer Care to Local Settings - Dr. Zainab Bagudu

    When it comes to bringing cervical cancer diagnosis and treatment to women everywhere, there is no stronger advocate than Dr. Zainab Bagudu. The pediatrician, former First Lady of Nigeria, founder of the Medicaid Cancer Foundation and now President-Elect of the global Union for International Cancer Control (UICC) is passionate about making cancer diagnosis and treatment available to everyone, ever
    January 14, 2025
    WHO Study Lists Top Endemic Pathogens for Which New Vaccines are Urgently Needed

    WHO Study Lists Top Endemic Pathogens for Which New Vaccines are Urgently Needed

    A recent WHO study identifies high-priority endemic pathogens urgently requiring new vaccines to address global health threats. The findings emphasize pathogens responsible for significant disease burdens, highlighting the need for accelerated vaccine research and development. This effort aligns with global health goals to prevent outbreaks, improve resilience against infectious diseases, and ensu
    December 10, 2024
    Unicef: Democratic Republic of the Congo Starts Mpox Vaccination in High-Priority Provinces

    Unicef: Democratic Republic of the Congo Starts Mpox Vaccination in High-Priority Provinces

    The Democratic Republic of the Congo (DRC) has started vaccinating vulnerable groups against mpox in high-priority provinces. Supported by UNICEF, WHO, Gavi, and Africa CDC, 265,000 doses of the MVA-BN vaccine have been delivered. The vaccination campaign focuses on protecting health workers, contacts of mpox cases, and immunocompromised individuals. Mpox has heavily affected children, with over 3
    October 15, 2024
    Sabin Vaccine Institute Delivers Marburg Vaccines to Combat Outbreak in Rwanda

    Sabin Vaccine Institute Delivers Marburg Vaccines to Combat Outbreak in Rwanda

    Sabin has delivered investigational Marburg vaccines to Rwanda to combat a deadly outbreak. The initial batch of 700 doses, followed by 1,000 more, is being used to vaccinate frontline healthcare workers in an open-label study. The outbreak, declared on September 27, has caused 46 infections and 12 deaths. Sabin's vaccine, based on the cAd3 platform, has shown promise in ongoing trials, with no sa
    October 14, 2024
    Unicef Polio Vaccines Protect Children in Gaza Strip

    Unicef Polio Vaccines Protect Children in Gaza Strip

    In Gaza, UNICEF is working to protect children from polio by providing vaccines amid challenging conditions. In collaboration with partners, UNICEF has successfully delivered over 800,000 doses of polio vaccine to ensure children remain safe from the disease. This effort is part of a broader campaign to strengthen immunization systems and safeguard children’s health, despite ongoing conflicts and
    October 14, 2024
    Watch Sabin's "Getting to Zero" Episode 7: Uniting to Eliminate Cervical Cancer in Africa

    Watch Sabin's "Getting to Zero" Episode 7: Uniting to Eliminate Cervical Cancer in Africa

    In our latest episode of "Getting to Zero," World Health Organization Africa regional director Dr. Matshidiso Moeti sits down with Anuradha Gupta to share why the Global HPV Consortium gives her hope. To watch this session, click the link below! Watch this Episode!
    August 30, 2024
    Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine

    Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine

    In a critical step forward to combat a deadly disease that has no approved vaccines, Sabin launched a Phase 2 clinical trial for our Sudan ebolavirus vaccine. Adult volunteers received the single-dose vaccine at our partner site, the Makerere University Walter Reed Project (MUWRP) in Uganda. The trial will soon expand to Kenya. Similar-stage human trials are also underway for a Sabin vaccine again
    August 30, 2024
    2023 WHO and UNICEF Estimates of National Immunization Coverage (WUENIC) Data Portal, Webinar Recording, and Results

    2023 WHO and UNICEF Estimates of National Immunization Coverage (WUENIC) Data Portal, Webinar Recording, and Results

    The 2023 WHO and UNICEF Estimates of National Immunization Coverage (WUENIC) data have been release and reveal an increase in zero-dose children for both DTP3 and MCV1 compared to 2019, with rates falling short of IA2030 goals. MCV1 coverage is notably lower than DTP3, though signs of recovery are seen as DTP3 levels in low-income countries stabilize. Despite some progress, zero-dose children rema
    July 25, 2024
    WHO Global Action Plan on Promoting the Health of Refugees and Migrants, 2019–2030

    WHO Global Action Plan on Promoting the Health of Refugees and Migrants, 2019–2030

    In 2017, the Seventieth World Health Assembly reviewed the report on promoting the health of refugees and migrants (A70/24) and the Executive Board's decision (EB140(9)), leading to a request for the Director-General to develop a global health strategy for these populations. A draft of the WHO global action plan for 2019–2023 was presented at the Seventy-second World Health Assembly in May 2019, r
    July 16, 2024
    WHO: Shipment of Newest Malaria Vaccine, R21, to Central African Republic Marks Latest Milestone for Child Survival/ La livraison du nouveau vaccin contre le paludisme, R21, en République Centrafricaine marque une nouvelle étape pour la survie des enfants

    WHO: Shipment of Newest Malaria Vaccine, R21, to Central African Republic Marks Latest Milestone for Child Survival/ La livraison du nouveau vaccin contre le paludisme, R21, en République Centrafricaine marque une nouvelle étape pour la survie des enfants

    The World Health Organization announced the shipment of the newest malaria vaccine, R21, to the Central African Republic. This milestone aims to enhance child survival rates by addressing malaria, a major cause of child mortality in the region. The R21 vaccine promises to be a crucial tool in reducing the burden of malaria and improving public health outcomes. For more details, click the link belo
    June 20, 2024
    Gavi Board Approves Next Five Year Strategy; Outlines Plans to Support Access to New Vaccines, Global Health Security, and Sustainability

    Gavi Board Approves Next Five Year Strategy; Outlines Plans to Support Access to New Vaccines, Global Health Security, and Sustainability

    The Gavi Board has approved its 2030 strategy, focusing on new vaccine introductions, especially for malaria and other priority diseases. Key decisions include enhancing vaccine sovereignty for countries, supporting sustainable immunization programs, and addressing gaps in vaccine coverage. The strategy emphasizes equitable access to vaccines, innovation, and collaboration with partners to strengt
    June 20, 2024
    Contact
    Boost Community Support
    2000 Pennsylvania Ave, NW, Suite 7000 | Washington, DC 20006
    info@boostcommunity.org
    Links
    • Welcome to Boost
    Community engagement platform by Hivebrite.